ConductScience.org, home

Paper41565660

An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.

Zhang Y and 13 others. Nat Commun, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression. Papers, record 41565660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41565660

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.
PubMed
Journal
Nat Commun
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErbB ReceptorsMajor topic
Lung NeoplasmsMajor topic
MutationMajor topic
GliomaMajor topic
Humans
Animals
Afatinib
Cell Line, Tumor
Phosphorylation
Mice
Disease Progression
Cell Proliferation
Protein Kinase Inhibitors
Mice, Nude
Female

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
32470821National Natural Science Foundation of China (National Science Foundation of China)PubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1974077Nature of the Thermal pretransition of synthetic phospholipids: dimyristolyl- and dipalmitoyllecithin.Biochemistry1976https://conductscience.org/library/papers/974077PubMed
234787778Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial.J Neurooncol2021https://conductscience.org/library/papers/34787778PubMed
329990498Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.Cancer Cell2018https://conductscience.org/library/papers/29990498PubMed
430854234Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer.Signal Transduct Target Ther2019https://conductscience.org/library/papers/30854234PubMed
515284455Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways.Science2004https://conductscience.org/library/papers/15284455PubMed
626636222Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms.J Chem Theory Comput2007https://conductscience.org/library/papers/26636222PubMed
78530489Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor.J Biol Chem1995https://conductscience.org/library/papers/8530489PubMed
839470721Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics.Nucleic Acids Res2025https://conductscience.org/library/papers/39470721PubMed
929462253Overview of current systemic management of EGFR-mutant NSCLC.Ann Oncol2018https://conductscience.org/library/papers/29462253PubMed
1037805108Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?Biochim Biophys Acta Rev Cancer2023https://conductscience.org/library/papers/37805108PubMed
1120837704Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.Mol Cell Biol2010https://conductscience.org/library/papers/20837704PubMed
1222588883Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.Cancer Discov2012https://conductscience.org/library/papers/22588883PubMed
1330075070Anomalous Effects of Velocity Rescaling Algorithms: The Flying Ice Cube Effect Revisited.J Chem Theory Comput2018https://conductscience.org/library/papers/30075070PubMed
1425079552Comprehensive molecular profiling of lung adenocarcinoma.Nature2014https://conductscience.org/library/papers/25079552PubMed
1524202392The quest to overcome resistance to EGFR-targeted therapies in cancer.Nat Med2013https://conductscience.org/library/papers/24202392PubMed
1635113553Lipid21: Complex Lipid Membrane Simulations with AMBER.J Chem Theory Comput2022https://conductscience.org/library/papers/35113553PubMed
1724803855Lipid14: The Amber Lipid Force Field.J Chem Theory Comput2014https://conductscience.org/library/papers/24803855PubMed
1838548752Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.Nat Commun2024https://conductscience.org/library/papers/38548752PubMed
1910677291The GxxxG motif: a framework for transmembrane helix-helix association.J Mol Biol2000https://conductscience.org/library/papers/10677291PubMed
2021367692Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21367692PubMed

See all 40 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41565660

GET https://conductscience.org/api/papers/v1/41565660/references?page=2